Navigation Links
Sensorin Raises Equity Financing to Launch Novel Industrial Sensing Venture

BURLINGAME, Calif., Oct. 21 /PRNewswire/ -- Sensorin, which is developing and commercializing a novel self-calibrating pH measurement platform for bioprocess applications, today announced the closing of its second round of equity funding. Use of proceeds from the financing includes product development, beta testing and launch of Sensorin's proprietary pH sensing system. Terms of the financing were not disclosed.

"Sensorin is funded by a distinguished group of individual investors with first-hand biopharmaceutical experience who are aware of the problems associated with current pH probes and who recognize the large commercial opportunity for better in-line pH measurement," said Carolyn Kahn, Ph.D., Sensorin president and CEO. "Sensorin's system represents a compelling solution for bioprocessing, including fixed and disposable fermentation systems and downstream processing."

"Improved pH control has the potential to significantly increase biopharmaceutical yields," commented Frank Jackson, former Vice President of Vacaville Product Operations for Genentech, Inc., and a Sensorin investor and advisor. "Although internally referenced approaches to measuring pH have been explored in academia, Sensorin has developed the only platform capable of in-line pH measurement without calibration, without drift and without fouling during extended periods of cell culture."

Sensorin obtained seed financing and began operations in the third quarter of 2007. The company rapidly demonstrated proof-of-concept for its proprietary technology platform, achieving this goal by the end of 2007. Sensorin is currently developing a beta version of its system for customer testing, with a prospective commercial launch in 2009.

Sensorin intends to address biologics manufacturing with its first- generation pH measurement system. The technology can be extended to other industrial pH applications, including waste-water processing and oil, gas and biofuels production.

About the Sensorin pH Measurement System

The Sensorin(TM) pH measurement system combines reusable electronic components with Sensorin's innovative solid-state pH sensor embedded in a disposable probe. Using a proprietary, internally referenced approach that is self-calibrating and drift free and does not foul in cell culture, the Sensorin system enables in-line, operator-independent pH monitoring. Sensorin's pH probes are highly accurate, precise, robust and easy to use and are designed to integrate with existing pH control equipment for bioprocessing.

Sensorin's Board of Directors

In addition to Dr. Kahn, Sensorin's board members include chairman Alan M. Mendelson, general partner of Axiom Ventures; Steve Allen, Ph.D., Managing Director of LGC Forensics and former executive of Perkin-Elmer Instruments and Mettler Toledo; George Milne, Jr., Ph.D., Executive Chairman of Rib-X, Venture Partner of Radius Ventures and former EVP of Global Research and Development of Pfizer; and Linda Rubinstein, principal of RDJ Advisors and former CFO of Solexa.

About Sensorin

Sensorin is developing and commercializing a novel, proprietary and versatile sensing technology platform. The company is initially focusing on pH measurement in high-value manufacturing, where an internally referenced, self-calibrating system without drift is advantageous. The Sensorin system is solid state, reliable, accurate and robust for deployment in process applications. The company anticipates launching its pH sensing system for biologics manufacturing in 2009. For further information, please visit

For further information, contact:

Steve DiMattia

EVC Group, Inc.


SOURCE Sensorin
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
2. Vista Partners Updates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx), Raises Target Price to AU$1.65
3. Ameristar National Charity Golf Classic Raises More Than $1.1 Million for Buoniconti Fund to Cure Paralysis and Christopher & Dana Reeve Foundation
4. China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income
5. MacroGenics Raises $25M in Series D-2 Financing
6. Yongye Biotechnology International Raises $9.4 Million in Private Placement
7. Proteolix Raises $79 Million in Series C Financing
8. Bacon Eating Contest Raises Money for American Heart Association
9. Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results
10. Pacific Biosciences Raises $100 Million to Fund Commercial Product Development
11. Alseres Pharmaceuticals, Inc. Raises $5 Million
Post Your Comments:
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... 23, 2016 Houston Methodist Willowbrook Hospital ... Sports Association to serve as their official health ... Methodist Willowbrook will provide sponsorship support, athletic training ... association coaches, volunteers, athletes and families. ... Sports Association and to bring Houston Methodist quality ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
Breaking Biology Technology:
(Date:4/19/2016)... 2016 The new GEZE SecuLogic ... web-based "all-in-one" system solution for all door components. It ... the door interface with integration authorization management system, and ... The minimal dimensions of the access control and the ... installations offer considerable freedom of design with regard to ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):